Metastatic dissemination of ovarian tumors involves the invasion of tumor cell clusters into the mesothelial cell lining of peritoneal cavity organs; however, the tumor-specific factors that allow ovarian cancer cells to spread are unclear. We used an in vitro assay that models the initial step of ovarian cancer metastasis, clearance of the mesothelial cell layer, to examine the clearance ability of a large panel of both established and primary ovarian tumor cells. Comparison of the gene and protein expression profiles of clearance-competent and clearance-incompetent cells revealed that mesenchymal genes are enriched in tumor populations that display strong clearance activity, while epithelial genes are enriched in those with weak or undetectable activity. Overexpression of transcription factors SNAI1, TWIST1, and ZEB1, which regulate the epithelial-to-mesenchymal transition (EMT), promoted mesothelial clearance in cell lines with weak activity, while knockdown of the EMT-regulatory transcription factors TWIST1 and ZEB1 attenuated mesothelial clearance in ovarian cancer cell lines with strong activity. These findings provide important insights into the mechanisms associated with metastatic progression of ovarian cancer and suggest that inhibiting pathways that drive mesenchymal programs may suppress tumor cell invasion of peritoneal tissues.
Rachel A. Davidowitz, Laura M. Selfors, Marcin P. Iwanicki, Kevin M. Elias, Alison Karst, Huiying Piao, Tan A. Ince, Michael G. Drage, Judy Dering, Gottfried E. Konecny, Ursula Matulonis, Gordon B. Mills, Dennis J. Slamon, Ronny Drapkin, Joan S. Brugge
Title and authors | Publication | Year |
---|---|---|
APOBEC3A drives ovarian cancer metastasis by altering epithelial-to-mesenchymal transition
Jessica Devenport, Thi Tran, Brooke R. Harris, Dylan Fingerman, Rachel A. DeWeerd, Lojain H Elkhidir, Danielle LaVigne, Katherine Fuh, Lulu Sun, Jeffrey J. Bednarski, Ronny Drapkin, Mary M Mullen, Abby M. Green |
JCI Insight | 2025 |
Norepinephrine induces anoikis resistance in high-grade serous ovarian cancer precursor cells
Hunter Reavis, Stefan Gysler, Grace McKenney, Matthew Knarr, Hannah Lusk, Priyanka Rawat, Hannah Rendulich, Marilyn Mitchell, Dara S. Berger, Jamie S. Moon, Suyeon Ryu, Monica Mainigi, Marcin Iwanicki, Dave Hoon, Laura Sanchez, Ronny Drapkin |
JCI Insight | 2024 |
Harnessing function of EMT in cancer drug resistance: a metastasis regulator determines chemotherapy response.
Ebrahimi N, Manavi MS, Faghihkhorasani F, Fakhr SS, Baei FJ, Khorasani FF, Zare MM, Far NP, Rezaei-Tazangi F, Ren J, Reiter RJ, Nabavi N, Aref AR, Chen C, Ertas YN, Lu Q |
Cancer metastasis reviews | 2024 |
Reciprocal crosstalk between Th17 and mesothelial cells promotes metastasis‐associated adhesion of ovarian cancer cells
Neuhaus F, Lieber S, Shinkevich V, Steitz AM, Raifer H, Roth K, Finkernagel F, Worzfeld T, Burchert A, Keber C, Nist A, Stiewe T, Reinartz S, Beutgen VM, Graumann J, Pauck K, Garn H, Gaida M, Müller R, Huber M |
Clinical and Translational Medicine | 2024 |
Enhancing PKA-dependent mesothelial barrier integrity reduces ovarian cancer transmesothelial migration via inhibition of contractility
Jazwinska DE, Cho Y, Zervantonakis IK |
iScience | 2024 |
The Gut Microbiome in Aging and Ovarian Cancer
Dominique GM, Hammond C, Stack MS |
Aging and cancer | 2024 |
LCP1 promotes ovarian cancer cell resistance to olaparib by activating the JAK2/STAT3 signalling pathway
Gai M, Zhao L, Li H, Jin G, Li W, Wang F, Liu M |
Cancer Biology & Therapy | 2024 |
Plakin Expression in Serous Epithelial Ovarian Cancer Has the Potential to Impede Metastatic Spread and Epithelial–Mesenchymal Transition: A Comparative Expression Analysis of Immunohistochemical and In Silico Datasets
Wesley T, Escalona RM, Kannourakis G, Ahmed N |
Cancers | 2024 |
MNRR1 is a driver of ovarian cancer progression
Chehade H, Purandare N, Fox A, Adzibolosu N, Jayee S, Singh A, Tedja R, Gogoi R, Aras S, Grossman LI, Mor G, Alvero AB |
Translational oncology | 2023 |
LINE-1 ORF1p as a candidate biomarker in high grade serous ovarian carcinoma
Sato S, Gillette M, de Santiago PR, Kuhn E, Burgess M, Doucette K, Feng Y, Mendez-Dorantes C, Ippoliti PJ, Hobday S, Mitchell MA, Doberstein K, Gysler SM, Hirsch MS, Schwartz L, Birrer MJ, Skates SJ, Burns KH, Carr SA, Drapkin R |
Scientific Reports | 2023 |
Model of collective detachment in high-grade serous ovarian cancer demonstrates that tumor spheroids produce ECM to support metastatic processes
Micek HM, Rosenstock L, Ma Y, Hielsberg C, Montemorano L, Gari MK, Ponik SM, Kreeger PK |
2023 | |
Host obesity alters the ovarian tumor immune microenvironment and impacts response to standard of care chemotherapy
Liu Y, Yang J, Hilliard TS, Wang Z, Johnson J, Wang W, Harper EI, Ott C, O\u2019Brien C, Campbell L, Crowley B, Grisoli S, Stavrou NM, Juncker-Jensen A, Stack MS |
Journal of experimental & clinical cancer research : CR | 2023 |
Positional influence on cellular transcriptional identity revealed through spatially segmented single-cell transcriptomics
Morse DB, Michalowski AM, Ceribelli M, Jonghe JD, Vias M, Riley D, Davies-Hill T, Voss T, Pittaluga S, Muus C, Liu J, Boyle S, Weitz DA, Brenton JD, Buenrostro JD, Knowles TP, Thomas CJ |
Cell Systems | 2023 |
Exploiting a living biobank to delineate mechanisms underlying disease-specific chromosome instability.
Nelson L, Barnes BM, Tighe A, Littler S, Coulson-Gilmer C, Golder A, Desai S, Morgan RD, McGrail JC, Taylor SS |
Chromosome Research | 2023 |
Single‐cell RNA sequencing captures patient‐level heterogeneity and associated molecular phenotypes in breast cancer pleural effusions
Whitfield HJ, Berthelet J, Mangiola S, Bell C, Anderson RL, Pal B, Yeo B, Papenfuss AT, Merino D, Davis MJ |
Clinical and Translational Medicine | 2023 |
Glucocorticoid Receptor Activation in Lobular Breast Cancer Is Associated with Reduced Cell Proliferation and Promotion of Metastases
Porter BA, Frerich C, Lainé M, Clark AB, Durdana I, Lee J, Taya M, Sahoo S, Greene GL, Bennett L, Conzen SD |
Cancers | 2023 |
Genetic and Functional Modifications Associated with Ovarian Cancer Cell Aggregation and Limited Culture Conditions
Grieco JP, Compton SL, Davis GN, Guinan J, Schmelz EM |
International journal of molecular sciences | 2023 |
Defining the Role of Metastasis-Initiating Cells in Promoting Carcinogenesis in Ovarian Cancer.
Wang J, Ford JC, Mitra AK |
Biology | 2023 |
Stromal DDR2 promotes ovarian cancer metastasis through regulation of metabolism and secretion of extracellular matrix proteins
Schab AM, Greenwade MM, Stock E, Lomonosova E, Cho K, Grither WR, Noia H, Wilke D, Mullen MM, Hagemann AR, Hagemann IS, Thaker PH, Kuroki LM, McCourt CK, Khabele D, Powell MA, Mutch DG, Zhao P, Shriver LP, Patti GJ, Longmore GD, Fuh KC |
Molecular cancer research : MCR | 2023 |
Ovarian Cancer Cells in Ascites Form Aggregates That Display a Hybrid Epithelial-Mesenchymal Phenotype and Allows Survival and Proliferation of Metastasizing Cells
S Capellero, J Erriquez, C Battistini, R Porporato, G Scotto, F Borella, M Renzo, G Valabrega, M Olivero |
International journal of molecular sciences | 2022 |
Wnt5A and TGFβ1 Converges through YAP1 Activity and Integrin Alpha v Up-Regulation Promoting Epithelial to Mesenchymal Transition in Ovarian Cancer Cells and Mesothelial Cell Activation
Z Dehghani-Ghobadi, S Hasani, E Arefian, G Hossein |
Cells | 2022 |
Metabolic Reprogramming of Ovarian Cancer Spheroids during Adhesion
Compton SL, Grieco JP, Gollamudi B, Bae E, Van Mullekom JH, Schmelz EM |
Cancers | 2022 |
Gata6+ resident peritoneal macrophages promote the growth of liver metastasis
Hossain M, Shim R, Lee WY, Sharpe AH, Kubes P |
Nature Communications | 2022 |
DDR2 Expression in Cancer-Associated Fibroblasts Promotes Ovarian Cancer Tumor Invasion and Metastasis through Periostin-ITGB1
Akinjiyan FA, Dave RM, Alpert E, Longmore GD, Fuh KC |
Cancers | 2022 |
Compound C Inhibits Ovarian Cancer Progression via PI3K-AKT-mTOR-NFκB Pathway.
Ghoneum A, Gonzalez D, Afify H, Shu J, Hegarty A, Adisa J, Kelly M, Lentz S, Salsbury F, Said N |
Cancers | 2022 |
Metabolic Reprogramming and Lipophagy Mediates Survival of Ascites Derived Metastatic Ovarian Cancer Cells.
S SK, N Swamy S, Devaraj VR, Premalatha CS, Pallavi VR, Sagar BC, Shinde DD, Gawari R |
Asian Pacific Journal of Cancer Prevention | 2022 |
Agent-based modeling predicts RAC1 is critical for ovarian cancer metastasis.
Rivera M, Toledo-Jacobo L, Romero E, Oprea TI, Moses ME, Hudson LG, Wandinger-Ness A, Grimes MM |
Molecular biology of the cell | 2022 |
Ovarian Cancer Ascites Inhibits Transcriptional Activation of Natural Killer Cells Partly Through CA125
Fraser CC, Jia B, Hu G, Johani LI, Fritz-Klaus R, Ham JD, Fichorova RN, Elias KM, Cramer DW, Patankar MS, Chen J |
Journal of immunology (Baltimore, Md. : 1950) | 2022 |
Cancer associated mesothelial cells promote ovarian cancer chemoresistance through paracrine osteopontin signaling
Jin Qian, Bauer L. LeSavage, Kelsea M. Hubka, Chenkai Ma, Suchitra Natarajan, Joshua T Eggold, Yiren Xiao, Katherine C Fuh, Venkatesh Krishnan, Annika Enejder, Sarah Heilshorn, Oliver Dorigo, Erinn B. Rankin |
Journal of Clinical Investigation | 2021 |
TGFβ signaling networks in ovarian cancer progression and plasticity
A Kumari, Z Shonibare, M Monavarian, RC Arend, NY Lee, GJ Inman, K Mythreye |
Clinical & Experimental Metastasis | 2021 |
Cellular models of development of ovarian high‐grade serous carcinoma: A review of cell of origin and mechanisms of carcinogenesis
J Mei, H Tian, HS Huang, CF Hsu, Y Liou, N Wu, W Zhang, TY Chu |
Cell Proliferation | 2021 |
ZNF471 modulates EMT and functions as methylation regulated tumor suppressor with diagnostic and prognostic significance in cervical cancer
S Bhat, SP Kabekkodu, D Adiga, R Fernandes, V Shukla, P Bhandari, D Pandey, K Sharan, K Satyamoorthy |
Cell Biology and Toxicology | 2021 |
Asparagus officinalis Exhibits Anti-Tumorigenic and Anti-Metastatic Effects in Ovarian Cancer
G Xu, W Kong, Z Fang, Y Fan, Y Yin, SA Sullivan, AQ Tran, LH Clark, W Sun, T Hao, L Zhao, C Zhou, VL Bae-Jump |
Frontiers in Oncology | 2021 |
Topological defects in the mesothelium suppress ovarian cancer cell clearance
J Zhang, N Yang, PK Kreeger, J Notbohm |
2021 | |
Utilization of a 3-D tissue engineered model to investigate the effects of perfusion on gynecologic cancer biology
A Martinez, MS Buckley, CB Scalise, D Wang, AA Katre, MJ Birrer, JL Berry, RC Arend |
Journal of Tissue Engineering | 2021 |
Ovarian Cancer-Driven Mesothelial-to-Mesenchymal Transition is Triggered by the Endothelin-1/β-arr1 Axis
DD Rio, I Masi, V Caprara, F Spadaro, F Ottavi, R Strippoli, P Sandoval, M López-Cabrera, RS de la Cuesta, A Bagnato, L Rosanò |
Frontiers in Cell and Developmental Biology | 2021 |
Regulation of invasion and peritoneal dissemination of ovarian cancer by mesothelin manipulation
R Coelho, S Ricardo, AL Amaral, YL Huang, M Nunes, JP Neves, N Mendes, MN López, C Bartosch, V Ferreira, R Portugal, JM Lopes, R Almeida, V Heinzelmann-Schwarz, F Jacob, L David |
Oncogenesis | 2020 |
Transient commensal clonal interactions can drive tumor metastasis
SN Amara, HJ Kuiken, LM Selfors, T Butler, ML Leung, CT Leung, EP Kuhn, T Kolarova, C Hage, K Ganesh, R Panayiotou, R Foster, BR Rueda, A Aktipis, P Spellman, TA Ince, J Xiu, M Oberley, Z Gatalica, N Navin, GB Mills, RT Bronson, JS Brugge |
Nature Communications | 2020 |
Ovarian BDNF promotes survival, migration, and attachment of tumor precursors originated from p53 mutant fallopian tube epithelial cells
M Kang, KY Chong, TM Hartwich, F Bi, AK Witham, D Patrick, MJ Morrisson, SL Cady, AP Cerchia, D Kelk, Y Liu, J Nucci, O Madarikan, D Ueno, BM Shuch, Y Yang-Hartwich |
Oncogenesis | 2020 |
Collagen-rich omentum is a premetastatic niche for integrin α2-mediated peritoneal metastasis
YL Huang, CY Liang, D Ritz, R Coelho, D Septiadi, M Estermann, C Cumin, N Rimmer, A Schötzau, MN López, A Fedier, M Konantz, T Vlajnic, D Calabrese, C Lengerke, L David, B Rothen-Rutishauser, F Jacob, V Heinzelmann-Schwarz |
eLife | 2020 |
L1 Cell Adhesion Molecule Confers Radioresistance to Ovarian Cancer and Defines a New Cancer Stem Cell Population
N Terraneo, F Jacob, C Peitzsch, A Dubrovska, C Krudewig, YL Huang, V Heinzelmann-Schwarz, R Schibli, M Béhé, J Grünberg |
Cancers | 2020 |
Lysophosphatidic acid modulates ovarian cancer multicellular aggregate assembly and metastatic dissemination
Y Klymenko, B Bos, L Campbell, E Loughran, Y Liu, J Yang, O Kim, MS Stack |
Scientific Reports | 2020 |
The Capacity of High-Grade Serous Ovarian Cancer Cells to Form Multicellular Structures Spontaneously along Disease Progression Correlates with Their Orthotopic Tumorigenicity in Immunosuppressed Mice
A Goyeneche, MA Lisio, L Fu, R Srinivasan, JV Capuccino, Z Gao, C Telleria |
Cancers | 2020 |
A single-cell landscape of high-grade serous ovarian cancer
B Izar, I Tirosh, EH Stover, I Wakiro, MS Cuoco, I Alter, C Rodman, R Leeson, MJ Su, P Shah, M Iwanicki, SR Walker, A Kanodia, JC Melms, S Mei, JR Lin, CB Porter, M Slyper, J Waldman, L Jerby-Arnon, O Ashenberg, TJ Brinker, C Mills, M Rogava, S Vigneau, PK Sorger, LA Garraway, PA Konstantinopoulos, JF Liu, U Matulonis, BE Johnson, O Rozenblatt-Rosen, A Rotem, A Regev |
Nature Medicine | 2020 |
SUSD2 expression correlates with decreased metastasis and increased survival in a high-grade serous ovarian cancer xenograft murine model
JN Sheets, ME Patrick, KA Egland |
Oncotarget | 2020 |
Ovarian Cancer Dissemination—A Cell Biologist’s Perspective
S Farsinejad, T Cattabiani, T Muranen, M Iwanicki |
Cancers | 2019 |
Productive Cross-Talk with the Microenvironment: A Critical Step in Ovarian Cancer Metastasis
Aziz, Agarwal, Dasari, Mitra |
Cancers | 2019 |
Collagen Remodeling in the Hypoxic Tumor-Mesothelial Niche Promotes Ovarian Cancer Metastasis
S Natarajan, KM Foreman, MI Soriano, NS Rossen, H Shehade, DR Fregoso, JT Eggold, V Krishnan, O Dorigo, AJ Krieg, SC Heilshorn, S Sinha, KC Fuh, EB Rankin |
Cancer research | 2019 |
Metastasis Organotropism: Redefining the Congenial Soil
Y Gao, I Bado, H Wang, W Zhang, JM Rosen, XH Zhang |
Developmental Cell | 2019 |
Identification of different gene expressions between diffuse- and intestinal-type spheroid-forming gastric cancer cells
JW Lee, JS Sung, YS Park, S Chung, YH Kim |
Gastric Cancer | 2019 |
Methods for Systematic Identification of Membrane Proteins for Specific Capture of Cancer-Derived Extracellular Vesicles
MP Zaborowski, K Lee, YJ Na, A Sammarco, X Zhang, M Iwanicki, PS Cheah, HY Lin, M Zinter, CY Chou, G Fulci, BA Tannous, CP Lai, MJ Birrer, R Weissleder, H Lee, XO Breakefield |
Cell Reports | 2019 |
Inhibitory effect of carbonyl reductase 1 against peritoneal progression of ovarian cancer: evaluation by ex vivo 3D-human peritoneal model
H Oikiri, Y Asano, M Matsusaki, M Akashi, H Shimoda, Y Yokoyama |
Molecular Biology Reports | 2019 |
USP1 links platinum resistance to cancer cell dissemination by regulating Snail stability
M Sonego, I Pellarin, A Costa, GL Vinciguerra, M Coan, A Kraut, S DAndrea, A DallAcqua, DC Castillo-Tong, D Califano, S Losito, R Spizzo, Y Couté, A Vecchione, B Belletti, M Schiappacassi, G Baldassarre |
Science Advances | 2019 |
Exosomes promote pre-metastatic niche formation in ovarian cancer
W Feng, DC Dean, FJ Hornicek, H Shi, Z Duan |
Molecular Cancer | 2019 |
A biomimetic pancreatic cancer on-chip reveals endothelial ablation via ALK7 signaling
DH Nguyen, E Lee, S Alimperti, RJ Norgard, A Wong, JJ Lee, J Eyckmans, BZ Stanger, CS Chen |
Science Advances | 2019 |
Multicellular detachment generates metastatic spheroids during intra-abdominal dissemination in epithelial ovarian cancer
SA Habyan, C Kalos, J Szymborski, L McCaffrey |
Oncogene | 2018 |
TWIST1 induces expression of discoidin domain receptor 2 to promote ovarian cancer metastasis
WR Grither, LM Divine, EH Meller, DJ Wilke, RA Desai, AJ Loza, P Zhao, A Lohrey, GD Longmore, KC Fuh |
Oncogene | 2018 |
Role of tumor microenvironment in the pathobiology of ovarian cancer: Insights and therapeutic opportunities
A Ghoneum, H Afify, Z Salih, M Kelly, N Said |
Cancer Medicine | 2018 |
Role of tumor microenvironment in ovarian cancer pathobiology
A Ghoneum, H Afify, Z Salih, M Kelly, N Said |
Oncotarget | 2018 |
Ovarian Cancers: Genetic Abnormalities, Tumor Heterogeneity and Progression, Clonal Evolution and Cancer Stem Cells
U Testa, E Petrucci, L Pasquini, G Castelli, E Pelosi |
Medicines | 2018 |
Regulation of Ovarian Cancer Prognosis by Immune Cells in the Tumor Microenvironment
ML Drakes, PJ Stiff |
Cancers | 2018 |
Targeting the Microenvironment in High Grade Serous Ovarian Cancer
N Nwani, L Sima, W Nieves-Neira, D Matei |
Cancers | 2018 |
Mucins and Truncated O-Glycans Unveil Phenotypic Discrepancies between Serous Ovarian Cancer Cell Lines and Primary Tumours
R Coelho, L Marcos-Silva, N Mendes, D Pereira, C Brito, F Jacob, C Steentoft, U Mandel, H Clausen, L David, S Ricardo |
International journal of molecular sciences | 2018 |
ADH1B promotes mesothelial clearance and ovarian cancer infiltration
KM Gharpure, OD Lara, Y Wen, S Pradeep, C LaFargue, C Ivan, R Rupaimoole, W Hu, LS Mangala, SY Wu, AS Nagaraja, K Baggerly, AK Sood |
Oncotarget | 2018 |
Modeling the effect of ascites-induced compression on ovarian cancer multicellular aggregates
Y Klymenko, RB Wates, H Weiss-Bilka, R Lombard, Y Liu, L Campbell, O Kim, D Wagner, MJ Ravosa, MS Stack |
Disease models & mechanisms | 2018 |
The Unique Molecular and Cellular Microenvironment of Ovarian Cancer
T Worzfeld, EP von Strandmann, M Huber, T Adhikary, U Wagner, S Reinartz, R Müller |
Frontiers in Oncology | 2017 |
Inhibition of the integrin/FAK signaling axis and c-Myc synergistically disrupts ovarian cancer malignancy
B Xu, J Lefringhouse, Z Liu, D West, LA Baldwin, C Ou, L Chen, D Napier, L Chaiswing, LD Brewer, DS Clair, O Thibault, JR van Nagell, BP Zhou, R Drapkin, JA Huang, ML Lu, FR Ueland, XH Yang |
Oncogenesis | 2017 |
Cadherin composition and multicellular aggregate invasion in organotypic models of epithelial ovarian cancer intraperitoneal metastasis
Y Klymenko, O Kim, E Loughran, J Yang, R Lombard, M Alber, MS Stack |
Oncogene | 2017 |
Novel Intraperitoneal Treatment With Non-Thermal Plasma-Activated Medium Inhibits Metastatic Potential of Ovarian Cancer Cells
K Nakamura, Y Peng, F Utsumi, H Tanaka, M Mizuno, S Toyokuni, M Hori, F Kikkawa, H Kajiyama |
Scientific Reports | 2017 |
Post-translational modification of the membrane type 1 matrix metalloproteinase (MT1-MMP) cytoplasmic tail impacts ovarian cancer multicellular aggregate dynamics
J Yang, WC Kasberg, A Celo, Z Liang, K Quispe, MS Stack |
The Journal of biological chemistry | 2017 |
E-cadherin: A determinant molecule associated with ovarian cancer progression, dissemination and aggressiveness
M Rosso, B Majem, L Devis, L Lapyckyj, MJ Besso, M Llauradó, MF Abascal, ML Matos, L Lanau, J Castellví, JL Sánchez, AP Benavente, A Gil-Moreno, J Reventós, AS Margalef, M Rigau, MH Vazquez-Levin, JS Castresana |
PloS one | 2017 |
Recent Advances in Understanding, Diagnosing, and Treating Ovarian Cancer
K Mills, K Fuh |
F1000Research | 2017 |
An activity-dependent proximity ligation platform for spatially resolved quantification of active enzymes in single cells
G Li, JE Montgomery, MA Eckert, JW Chang, SM Tienda, E Lengyel, RE Moellering |
Nature Communications | 2017 |
Mutant p53 regulates ovarian cancer transformed phenotypes through autocrine matrix deposition
Marcin Iwanicki, Hsing-Yu Chen, Claudia Iavarone, Ioannis Zervantonakis, Taru Muranen, Marian Novak, Tan Ince, Ronny Drapkin, Joan Brugge |
JCI Insight | 2016 |
Cisplatin Resistant Spheroids Model Clinically Relevant Survival Mechanisms in Ovarian Tumors
W Chowanadisai, SM Messerli, DH Miller, JE Medina, JW Hamilton, MA Messerli, AS Brodsky, S Orsulic |
PloS one | 2016 |
Cyclin G2 inhibits epithelial-to-mesenchymal transition by disrupting Wnt/β-catenin signaling
S Bernaudo, M Salem, X Qi, W Zhou, C Zhang, W Yang, D Rosman, Z Deng, G Ye, B Yang, B Vanderhyden, Z Wu, C Peng |
Oncogene | 2016 |
SUSD2 expression in high-grade serous ovarian cancer correlates with increased patient survival and defective mesothelial clearance
JN Sheets, M Iwanicki, JF Liu, BE Howitt, MS Hirsch, JA Gubbels, R Drapkin, KA Egland |
Oncogenesis | 2016 |
Ginsenoside-Rb1 targets chemotherapy-resistant ovarian cancer stem cells via simultaneous inhibition of Wnt/β-catenin signaling and epithelial-to-mesenchymal transition
S Deng, CK Wong, HC Lai, AS Wong |
Oncotarget | 2016 |
The expression of Nectin-4 on the surface of ovarian cancer cells alters their ability to adhere, migrate, aggregate, and proliferate
KL Boylan, PC Buchanan, RD Manion, DM Shukla, K Braumberger, C Bruggemeyer, AP Skubitz |
Oncotarget | 2016 |
Functional characterization of a panel of high-grade serous ovarian cancer cell lines as representative experimental models of the disease
J Haley, S Tomar, N Pulliam, S Xiong, SM Perkins, AR Karpf, S Mitra, KP Nephew, AK Mitra |
Oncotarget | 2016 |
Characterization of twenty-five ovarian tumour cell lines that phenocopy primary tumours
TA Ince, AD Sousa, MA Jones, JC Harrell, ES Agoston, M Krohn, LM Selfors, W Liu, K Chen, M Yong, P Buchwald, B Wang, KS Hale, E Cohick, P Sergent, A Witt, Z Kozhekbaeva, S Gao, AT Agoston, MA Merritt, R Foster, BR Rueda, CP Crum, JS Brugge, GB Mills |
Nature Communications | 2015 |
EMT-Inducing Molecular Factors in Gynecological Cancers
L Campo, C Zhang, EK Breuer |
BioMed Research International | 2015 |
The Mesothelial Origin of Carcinoma Associated-Fibroblasts in Peritoneal Metastasis
A Rynne-Vidal, J Jiménez-Heffernan, C Fernández-Chacón, M López-Cabrera, P Sandoval |
Cancers | 2015 |
Dynamic Change in p63 Protein Expression during Implantation of Urothelial Cancer Clusters
T Yoshida, H Okuyama, M Nakayama, H Endo, Y Tomita, N Nonomura, K Nishimura, M Inoue |
Neoplasia (New York, N.Y.) | 2015 |
Imaging innate immune responses at tumour initiation: new insights from fish and flies
Y Feng, P Martin |
Nature Reviews Cancer | 2015 |
Consensus reference gene(s) for gene expression studies in human cancers: end of the tunnel visible?
RN Sharan, ST Vaiphei, S Nongrum, J Keppen, M Ksoo |
Cellular Oncology | 2015 |
Lysophosphatidic Acid Initiates Epithelial to Mesenchymal Transition and Induces β-Catenin-mediated Transcription in Epithelial Ovarian Carcinoma
RJ Burkhalter, SD Westfall, Y Liu, MS Stack |
The Journal of biological chemistry | 2015 |
Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer
DD Bowtell, S Böhm, AA Ahmed, PJ Aspuria, RC Bast, V Beral, JS Berek, MJ Birrer, S Blagden, MA Bookman, JD Brenton, KB Chiappinelli, FC Martins, G Coukos, R Drapkin, R Edmondson, C Fotopoulou, H Gabra, J Galon, C Gourley, V Heong, DG Huntsman, M Iwanicki, BY Karlan, A Kaye, E Lengyel, DA Levine, KH Lu, IA McNeish, U Menon, SA Narod, BH Nelson, KP Nephew, P Pharoah, DJ Powell, P Ramos, IL Romero, CL Scott, AK Sood, EA Stronach, FR Balkwill |
Nature Reviews Cancer | 2015 |
Novel Axl-driven signaling pathway and molecular signature characterize high-grade ovarian cancer patients with poor clinical outcome.
Rea K, Pinciroli P, Sensi M, Alciato F, Bisaro B, Lozneanu L, Raspagliesi F, Centritto F, Cabodi S, Defilippi P, Avanzi GC, Canevari S, Tomassetti A |
Oncotarget | 2015 |
Mesothelial cells promote early ovarian cancer metastasis through fibronectin secretion
Hilary Kenny, Chun-Yi Chiang, Erin White, Elizabeth Schryver, Mohammed Habis, Iris Romero, Andras Ladanyi, Carla Penicka, Joshy George, Karl Matlin, Anthony Montag, Kristen Wroblewski, S. Diane Yamada, Andrew Mazar, David Bowtell, Ernst Lengyel |
Journal of Clinical Investigation | 2014 |
Three-dimensional modeling of ovarian cancer
EA White, HA Kenny, E Lengyel |
Advanced Drug Delivery Reviews | 2014 |
Ovarian cancer stem cells express ROR1, which can be targeted for anti–cancer-stem-cell therapy
S Zhang, B Cui, H Lai, G Liu, EM Ghia, GF Widhopf, Z Zhang, CC Wu, L Chen, R Wu, R Schwab, DA Carson, TJ Kipps |
Proceedings of the National Academy of Sciences | 2014 |
Establishment of a New Ovarian Cancer Cell Line CA5171
YC Chiang, WF Cheng, MC Chang, TP Lu, KT Kuo, HP Lin, CY Hsieh, CA Chen |
Reproductive sciences (Thousand Oaks, Calif.) | 2014 |